sr141716 has been researched along with spironolactone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bitencourt, RM; Pamplona, FA; Takahashi, RN | 1 |
| Achterberg, EJ; Trezza, V; Vanderschuren, LJ | 1 |
3 other study(ies) available for sr141716 and spironolactone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Corticosteroid-endocannabinoid loop supports decrease of fear-conditioned response in rats.
Topics: Adrenal Cortex Hormones; Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Conditioning, Classical; Dexamethasone; Endocannabinoids; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Male; Metyrapone; Mifepristone; Mineralocorticoid Receptor Antagonists; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Glucocorticoid; Rimonabant; Spironolactone | 2014 |
Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.
Topics: Analysis of Variance; Animals; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dizocilpine Maleate; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Memory Disorders; Mifepristone; Mineralocorticoid Receptor Antagonists; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reward; Rimonabant; Social Behavior; Spironolactone | 2014 |